An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
Once the nasal spray is absorbed through the membranes in the nose, it enters the bloodstream and works to stimulate melanin ...
An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...
Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.
ALK-Abelló has acquired rights to Neffy adrenaline nasal spray in Europe and Canada, amongst other countries, from ARS ...
Investor's Business Daily on MSN4d
ARS Pharma Jumps After Inking $145 Million Deal For Epinephrine Nasal SprayARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.
Amanda Gardner is a freelance health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York Daily News, Teachers & Writers Magazine ...
*In instances where patient numbers were not reported they were calculated from the percentages, and in instances where percentages were not reported, percentages were calculated from patient numbers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback